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1  | INTRODUC TION
In the past decades, risk assessment has become a focus of at-
tention in clinical research. Several periodontal risk assessment 
tools have been developed and validated to varying extents 
(Heitz-Mayfield, 2005; Lang, Suvan, & Tonetti, 2015). At the 11th 
European Workshop on Periodontology (2015), five risk assess-
ment tools were addressed in a systematic review (Lang et al., 
2015). Of the five, one risk assessment tool, the Periodontal Risk 
Assessment (PRA) (Lang & Tonetti, 2003) was highlighted as having 
been validated in nine international studies. All of these studies 
indicated that patients at high risk for periodontal re-infection and 
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Abstract
Objective: This treatment concept paper introduces a risk assessment tool, the 
Implant Disease Risk Assessment, (IDRA) which estimates the risk for a patient to 
develop peri-implantitis.
Materials and methods: The functional risk assessment diagram was constructed 
incorporating eight parameters, each with documented evidence for an association 
with peri-implantitis.
Results: The eight vectors of the diagram include (1) assessment of a history of 
periodontitis (2) percentage of sites with bleeding on probing (BOP) (3) number of 
teeth/implants with probing depths (PD) ≥5 mm (4) the ratio of periodontal bone 
loss (evaluated from a radiograph) divided by the patient's age (5) periodontitis sus-
ceptibility as described by the staging and grading categories from the 2017 World 
Workshop on the Classification of Periodontal and Peri-implant Diseases (Journal 
of Periodontology, 89 Suppl 1, S159-S172, 2018) (6) the frequency/compliance with 
supportive periodontal therapy (7) the distance in mm from the restorative margin 
of the implant-supported prosthesis to the marginal bone crest and (8) prosthesis-
related factors including cleanability and fit of the implant-supported prosthesis.
Conclusion: The combination of these factors in a risk assessment tool, IDRA, may be 
useful in identifying individuals at risk for development of peri-implantitis.
K E Y W O R D S
disease progression, disease susceptibility, patient compliance, peri-implant disease  
"peri-implant mucositis", peri-implantitis, periodontal diseases, periodontal pocket,  
risk assessment, risk factors, risk indicators
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progression of disease after active periodontal treatment could 
be identified by using the six criteria of the PRA. These criteria 
are summarized in a hexagonal functional diagram, that identifies 
patients as either being low-, moderate- or high-risk patients. The 
PRA is available  open access at the following website (http://www.
perio-tools.com/PRA) in 23 languages. Consequently, the PRA is 
widely used by the profession with a frequency of over 500 hits 
per day.
As the etiology and pathogenesis of peri-implant diseases have 
received increasing attention, it is time to develop a similar risk as-
sessment tool for the prediction of the development of peri-implan-
titis. While a risk assessment predominantly evaluates the subject 
risk, it may also address the implant site. The Implant Disease Risk 
Assessment (IDRA) is used with the purpose of minimizing the chance 
of developing peri-implant tissue breakdown. By understanding the 
key factors associated with the development of peri-implant dis-
eases documented in the literature the clinician may selectively ad-
dress such factors to improve the outcomes for implant therapy. The 
IDRA may be used to evaluate risk for both edentulous and partially 
dentate patients. However, with edentulous patients, there may be 
some limitations.
The analyses of results from recent studies addressing risk fac-
tors/indicators for biological complications associated with dental 
implants have identified eight important factors, listed below, that 
may contribute to the development of peri-implantitis. On the other 
hand, the control of such factors would minimize the chance of the 
development of biological complications.
2  | A SSIGNMENT OF RISK
As for the PRA, there is not one single factor that can be attrib-
uted to the development of peri-implant disease. By analyzing 
the current literature, the following eight parameters have been 
identified: 1. History of periodontitis 2. Percentage of sites with 
BOP 3. Prevalence of PD ≥ 5 mm. 4. Bone loss in relation to the 
patient's age. 5. Periodontitis susceptibility as analyzed by the 
2017 World Workshop on the Classification of Periodontal and 
Peri-implant Diseases (Tonetti, Greenwell, & Kornman, 2018) 6. 
Supportive periodontal therapy 7. Implant restorative depth 8. 
Prosthesis-related factors.
These eight parameters have been combined in an octagon that 
visualizes the risk for disease development (Figure 1). A comprehen-
sive evaluation using this functional diagram will provide an individ-
ual total risk profile and determine the need for measures targeting 
risk reduction. Each vector has its own scale for risk profiles. As ad-
ditional factors become evident from the literature modifications of 
the diagram may be appropriate.
There is overwhelming evidence that bacterial biofilms are the 
most important etiologic agents for the initiation and progression 
of peri-implant diseases (Berglundh et al., 2018). Studies assessing 
self-performed plaque control have shown a strong association with 
poor plaque control and peri-implantitis (Schwarz, Derks, Monje, & 
Wang, 2018). In patients with a history of periodontitis, the preva-
lence of peri-implant disease was greater when the full mouth plaque 
score (FMPS) was above 25% (Aguirre-Zorzano, Estefania-Fresco, 
Telletxea, & Bravo, 2015). However, studies have not yet identi-
fied the level of biofilm control compatible with the maintenance of 
peri-implant health. In addition, a plaque score obtained at a single 
time-point may not necessarily reflect the patients’ routine level of 
self-performed plaque control. The host response to the biofilm is 
considered more important than the plaque score per se; therefore, 
it is appropriate to relate plaque score to the inflammatory parame-
ter bleeding on probing percentage (BOP %). Hence, the percentage 
of BOP rather than the FMPS is included as a parameter in the risk 
assessment diagram.
2.1 | History of periodontitis
There is strong evidence from longitudinal and cross-sectional 
studies that patients with a history of periodontitis are suscep-
tible to peri-implantitis (Derks et al., 2016; Karoussis et al., 2003; 
Kordbacheh Changi, Finkelstein, & Papapanou, 2019; Roccuzzo, De, 
Angelis, Bonino, & Aglietta, 2010). Hence, a patient who has a history 
of periodontitis or who has lost teeth to be replaced by implants due 
to periodontitis is at high risk. In contrast, a patient having lost teeth 
due to caries, trauma or agenesis is at low risk for the development 
of peri-implantitis. The history of periodontitis can be evaluated by 
assessing the presence of periodontal bone loss on radiographs or by 
examining dental records to determine the reason for tooth loss. The 
patient may also be able to provide the reason for tooth loss.
2.2 | Percentage of sites with BOP
Bleeding on gentle probing represents an objective inflammatory 
parameter, which has been incorporated into known index systems, 
for the evaluation of periodontal (Löe & Silness, 1963; Mühlemann, 
1973) and peri-implant conditions (Mombelli, van Oosten, Schürch, 
& Lang, 1987). Percentage of sites with BOP may also be used as an 
individual assessment parameter representing the host response to 
the bacterial challenge.
The incorporation of the BOP% into the PRA established a 
BOP prevalence of 25% as a cutoff point between patients who 
maintained periodontal stability for 4 years and patients with re-
current disease in the same time frame (Joss, Adler, & Lang, 1994; 
Matuliene et al., 2008). Further evidence of BOP % (ranging be-
tween 20%–30%) determining a higher risk for periodontal disease 
progression was demonstrated in a number of studies (Badersten, 
Nilveus, & Egelberg, 1990; Claffey, Nylund, Kiger, Garrett, & 
Egelberg, 1990; Matuliene et al., 2008). Bleeding on probing at im-
plant sites was also shown to be associated with disease progres-
sion (Karlsson et al., 2019; Luterbacher, Mayfield, Brägger, & Lang, 
2000; Giovanni Serino & Turri, 2011). The percentage of BOP is, 
therefore, used as a second risk indicator in the IDRA functional 
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diagram. The scale runs in a quadratic mode of 9, 16, 25, 36, and 
>49% being the critical values on the vector. This assessment en-
compasses the BOP% for all tooth and implant sites. Individuals 
with low BOP % (<10%) may be regarded as patients with a low risk 
for disease development (Lang, Adler, Joss, & Nyman, 1990), while 
patients with BOP% >25% should be considered to be at higher 
risk for tissue breakdown.
2.3 | Prevalence of probing depths ≥5 mm
High numbers of deep periodontal pockets (PD ≥ 5 mm) and deep-
ening of pockets during SPT has been associated with high risk of 
periodontal disease progression (Badersten et al., 1990; Claffey 
et al., 1990). It has also been shown that putative periodontal 
pathogens from deep residual pockets at teeth may colonize im-
plant sites (Mombelli, Marxer, Gaberthuel, Grunder, & Lang, 1995). 
Furthermore, the presence of higher numbers of residual pockets 
was associated with peri-implantitis development in the medium 
(Cho-Yan Lee, Mattheos, Nixon, & Ivanovski, 2012) to long-term 
(Pjetursson et al., 2012). In assessing the patient's risk for peri-im-
plant disease development, the number of tooth and implant sites 
with a PD ≥ 5 mm is assessed as the third risk indicator in the IDRA 
functional diagram. The scale runs in a linear mode with 2, 4, 6, 8, 
≥10 being the critical values on this vector. Individuals with one or 
two pockets with a PD ≥ 5 mm may be regarded as patients at low 
risk, while patients with more than six sites with PD ≥ 5 mm are 
regarded as individuals at high risk for development of biological 
complications.
2.4 | Periodontal bone loss in relation to age
The extent and prevalence of periodontal attachment loss as 
evaluated by the height of alveolar bone on radiographs may rep-
resent the most obvious indicator of subject risk for periodontal 
F I G U R E  1   Implant Disease Risk Assessment (IDRA) functional diagram. Each vector represents one risk parameter with an area of 
relative risk. When factors are evaluated together low risk is represented by the area within the center of the octagon (green shading). 
Moderate risk is represented by the area of the octagon between the first and second ring in bold (yellow shading). High risk is represented 
by the area outside the second bold ring of the octagon (red shading). Parameters: History of Perio History of periodontitis (yes/no). 
BOP % Percentage of implant and tooth sites with positive BOP. PD ≥ 5 mm Number of sites with PD ≥ 5 mm at implants and teeth. BL/
Age Periodontal bone loss in relation to the patient's age. Bone loss is estimated from a periapical or bitewing radiograph at the most 
severely affected tooth—In periapical radiographs, the % alveolar bone loss is compared with the distance 1 mm apical from the cemento-
enamel junction to the root apex. In bitewing radiographs, the % alveolar bone loss is calculated with 10% per 1 mm. Perio Susceptibility 
The patient's susceptibility to periodontitis. Staging and Grading according to the 2017 World Workshop on Classification of Periodontal 
Diseases (Tonetti et al., 2018). SPT Supportive Periodontal Therapy (Compliant with SPT, recall interval ≤5 months, recall interval 6 months, 
casual attender, no supportive therapy). RM-Bone Distance from the restorative margin (RM) of the implant prosthesis to the marginal bone 
crest (STL–soft tissue level implant, >1.5 mm, <1.5 mm). This is determined from a radiograph. Prosthesis. Assessment of factors related 
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disease progression when related to the patient's age (Papapanou, 
Wennström, & Gröndahl, 1988).
Periodontal bone loss has been identified as a risk factor for the 
development of peri-implant disease in two large randomly selected 
population studies (Derks et al., 2016; Kordbacheh Changi et al., 
2019). Therefore, the extent of alveolar bone loss in relation to the 
patient's age is estimated as the fourth risk indicator for disease de-
velopment in the functional IDRA diagram.
The estimation of the loss of alveolar bone is performed in ei-
ther periapical radiographs in which the worst tooth site affected is 
grossly estimated in % of the root length or on bitewing radiographs 
in which the worst site affected is estimated in mm. On bitewing 
radiographs, 1 mm is considered to be equal to 10% bone loss. The 
percentage is then divided by the patients age resulting in a factor. 
As an example, a 40-year-old patient with 20% of bone loss at the 
worst affected site would score BL/age = 0.5. Another 40-year-old 
patient with 50% bone loss at the worst affected site would score 
BL/age = 1.5.
The scale runs in increments of 0.25 of the factor BL/age with 
0.5 being the critical value to discriminate between low and moder-
ate risk and 1.0 being the value for moderate and high risk. This, in 
turn, means that a patient who has lost a higher percentage of the 
alveolar bone than his/her age is at high risk regarding this vector in 
a multifactorial assessment.
2.5 | Periodontitis susceptibility
In 2017, the World Workshop on Classification of Periodontal and 
Peri-implant diseases proposed a new system for the classification 
of periodontal diseases encompassing extent, severity and com-
plexity in a staging modality (Tonetti et al., 2018). In addition, the 
progression rate and hence the susceptibility to disease was incor-
porated with a grading modality (Tonetti et al., 2018).
It, therefore, seems logical to add the staging and grading for 
periodontal disease as a vector influencing disease development and 
progression for peri-implant diseases.
According to the IDRA (Figure 1), only Stage 1 Grade A rep-
resents low risk. Stage 2 represents moderate (from the middle node 
in the moderate range) or higher risk. Stage 3 represents moderate 
(from the outer node in the moderate range) or higher risk. Stage 4 
represents high risk. Regarding grading: Grade B represents moder-
ate (from the middle node in the moderate range) or higher risk and 
Grade C represents high risk.
The number of teeth that have been lost due to periodontitis is 
incorporated in the staging of the 2017 classification.
As the evidence for an association with peri-implantitis re-
mains equivocal regarding cigarette smoking and diabetes mellitus, 
these modifying factors are considered as potential risk indicators 
or emerging risk factors (Schwarz et al., 2018). Therefore, they are 
not represented in the IDRA by individual vectors; instead, they are 
incorporated within the grading of the 2017 classification of peri-
odontal diseases. This classification assigns a non-smoker to Grade 
A (slow rate of progression), a smoker <10 cigarettes per day is Grade 
B (moderate rate of progression) and a smoker ≥10 cigarettes per day 
represents Grade C (high risk of progression).
A patient with no diagnosis of diabetes is assigned as Grade A 
(slow rate of progression). A patient with diabetes and HbA1c < 7.0% 
is Grade B (moderate rate of progression) and HbA1c ≥ 7.0% is Grade 
C (rapid rate of progression).
2.6 | Supportive periodontal therapy (SPT)
There is strong evidence that a regular recall system rendering ap-
propriate supportive care is of utmost importance for peri-implant 
health and stability (Costa et al., 2012; Monje et al., 2016; Roccuzzo, 
Bonino, Aglietta, & Dalmasso, 2012). Therefore, the sixth vector of 
the IDRA deals with the compliance of patients and supportive care 
rendered by the clinician. Obviously, no supportive care represents 
a high risk for peri-implant disease development while full compli-
ance with a recommended and calculated maintenance care inter-
val results in low risk for disease development. A systematic review 
(Monje et al., 2016) determined that a recall interval of less than or 
equal to 5 months, on average may represent a time frame compat-
ible with maintenance of peri-implant health.
2.7 | Distance from the restorative 
margin (RM) of the implant-supported prosthesis 
to the bone
A large population study identified the distance of ≤1.5 mm from 
the restorative margin of the implant-supported prosthesis to the 
marginal bone crest at time of restoration as a risk indicator for peri-
implantitis (Derks et al., 2016). Hence, it is relevant to consider this 
distance in a risk assessment for the development of peri-implantitis. 
While a soft tissue level implant usually has a supramucosal restora-
tive margin and hence represents low risk for disease development, 
a distance of the restorative margin to the bone crest of ≤1.5 mm 
was demonstrated to be at higher risk. Therefore, the IDRA func-
tional diagram assigns low risk for a soft tissue level implant, mod-
erate risk as a distance of 1.5 mm, and high risk as a distance of 
<1.5 mm. This is determined from a radiograph made at the time of 
restoration. If a radiograph at the time of prosthesis delivery is not 
available a radiograph should be taken at the time of examination 
and risk assessment.
2.8 | Implant prosthesis-related factors
Several studies have indicated that the design and contours of the 
implant-supported prosthesis may lead to areas that are not cleana-
ble. Consequently, biofilms accumulate and may initiate peri-implant 
disease (Serino & Ström, 2009). Furthermore, iatrogenic factors such 
as poor marginal fit and submucosal excess cement deposits provide 
     |  401HEITZ-MAYFIELD ET AL.
habitats for biofilm accumulation and hence are documented factors 
for the development of biological complications. Recently, this has 
been confirmed in a large population study by (Kordbacheh Changi 
et al., 2019). In order to represent a low risk for disease develop-
ment the prosthesis must be well-fitting, cleanable, screw-retained 
or with no excess cement. Conversely, an uncleanable poorly fitting 
prosthesis is at high risk to allow biofilm accumulation and hence 
develop peri-implant disease. The same applies for the presence of 
submucosal excess cement. A moderate risk may be attributed to a 
prosthesis which has compromised fit but accessible supramucosal 
margins. In the context of the IDRA, the term cleanable refers to the 
access for both the clinician and the patient to clean the prosthe-
sis. The patient's ability to clean the prosthesis will depend on their 
level of skill and dexterity which may change over time.
F I G U R E  2   A low IDRA risk patient has 
all parameters in the low-risk categories 










































F I G U R E  3   A moderate IDRA risk 
patient has at least two parameters in the 
moderate-risk category but at most one 
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3  | C alculat ing the pat ient 's  indiv idual 
implant disease r isk assessment IDR A
Based on the eight parameters specified above a multifunctional 
diagram (Octagon) is constructed for the IDRA (Figure 1). In this 
diagram the vectors have been formed on the basis of the scientific 
evidence available. It is expected that ongoing validation may result 
in slight modifications.
A low IDRA patient has all parameters in the low-risk catego-
ries or at the most one parameter in the moderate-risk category 
(Figure 2).
A moderate IDRA patient has at least two parameters in the 
moderate-risk category but at most one parameter in the high-risk 
category (Figure 3). A moderate IDRA patient may also have one pa-
rameter in the high-risk category with all other parameters in the 
low-risk categories.
A high-risk IDRA patient has at least two parameters in the high-
risk category (Figure 4).
In a high-risk patient who yields a high %BOP and high numbers 
of residual pockets (PD ≥ 5 mm), the patient's risk for peri-implant 
disease development may be reduced into a moderate IDRA cat-
egory if further successful periodontal therapy is provided. While 
these two parameters (%BOP, PD ≥ 5 mm) are easily modified by ad-
equate therapy other parameters such as prosthesis fit may require 
replacement of the prosthesis.
One  factor in the IDRA, history of periodontitis is unable to be 
modified and therefore must be accepted as a given. Compensation 
for this high risk may be achieved by minimizing the effect of the 
other parameters.
In an edentulous patient restored with an implant-supported 
prosthesis where the patient's history of periodontitis cannot be de-
termined this parameter is not assigned. Furthermore, in an edentu-
lous patient, it is not possible to assign the parameter bone loss/age.
If a patient has a history of peri-implantitis the risk assessment 
for the parameter “history of periodontitis” should be assigned as 
high.
This IDRA risk assessment tool will require validation through 
retrospective or prospective studies in multiple private practice and 
University settings.
In conclusion, the IDRA has the potential to be a useful tool 
for assessing risk for an individual patient after implant therapy. In 
addition, the IDRA may be useful as a checklist to identify modifi-
able risks prior to implant therapy and as a tool for the clinician to 
communicate the level of risk to the patient. The IDRA online tool is 
available open access at the following website (http://www.ircohe.
net/IDRA).
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